Limiting the daily eating window may provide brain benefits beyond those associated with weight loss.
Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to results from a small clinical trial. The pilot study followed older women with overweight or obesity during a weight-loss program and found modest improvements on certain thinking tests among participants who compressed their daily eating period rather than only cutting calories.
"Losing weight alone will ward off some of the aging-related cognitive decline, and these data suggest that there may be additional benefits if you stop eating 4 hours prior to going to sleep and reduce food intake to 8-9 hours per day, compared to the usual eating window of 12 hours per day," said Sue Shapses, PhD, RD, DFASN, professor at Rutgers University and Rutgers-RWJ Medical Center, the study's Principal Investigator.
Shapses and her colleagues presented the results at NUTRITION 2026, the American Society for Nutrition's flagship annual meeting.
Lifestyle changes could alter dementia risk
As populations grow older, Alzheimer's disease and other forms of dementia are becoming increasingly common. Women and people with overweight or obesity generally face a greater likelihood of developing these conditions. Although diet and other lifestyle habits have been associated with dementia risk, relatively little research has tested whether changing those factors can lower it.
Two eating schedules put to the test
The trial included 47 women between ages 50 and 79 who had overweight or obesity. Every participant received guidance to reduce daily calorie intake by 500 calories. Of the group, 26 women were instructed to consume all food within fewer than nine hours each day, while the remaining participants continued eating across a typical window of about 12 hours. Those assigned to time-restricted eating generally ate between 10 a.m. and 6 p.m. Their average eating period was 8.2 hours per day, compared with 12.3 hours among women following the standard schedule.
A shorter window improves select skills
After six months, women in both groups had lost an average of approximately 15 pounds. Despite similar weight loss, participants eating within an 8-9 hour period showed significantly greater improvements in spatial planning and problem-solving than those maintaining a 12-hour window. They also tended to make fewer mistakes on tests of memory and learning, although that difference was not statistically significant. No meaningful differences appeared in multitasking ability or reaction time.
"There was a modest effect of time-restricted eating to improve spatial planning and problem-solving and on reducing errors related to memory and learning," said Shapses. "These outcomes suggest a better ability to remember information during everyday tasks and reducing mistakes related to memory, attention and problem-solving. Reductions in the eating window predicted greater improvements."
Larger trials must confirm the findings
Because the pilot study involved a small number of participants, the researchers emphasized that larger trials are necessary to verify the results. They also intend to examine possible biological explanations for the apparent benefits, including links among circadian rhythms, nutrient-sensing pathways, inflammation and metabolic health.
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
Brazilian Tree Compounds Fight COVID-19 on Multiple Fronts
Scientists found compounds in a Brazilian tree that hit SARS-CoV-2 on multiple fronts, revealing a promising new lead in the search for COVID-19 treatments. Researchers have found that galloylquinic acids extracted from the leaves [...]
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
